Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial
Authors:
Open Access
- 9 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (7) , 877-889
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Heart Failure With Preserved, Borderline, and Reduced Ejection FractionJACC, 2017
- Role of Volume Redistribution in the Congestion of Heart FailureJournal of the American Heart Association, 2017
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJournal of Cardiac Failure, 2017
- Raising the pressure: Hemodynamic effects of splanchnic nerve stimulationJournal of Applied Physiology, 2017
- Epidemiology and aetiology of heart failureNature Reviews Cardiology, 2016
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- Evaluating Treatment Efficacy by Multiple End Points in Phase II Acute Heart Failure Clinical TrialsCirculation: Heart Failure, 2012
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection FractionCirculation, 2012
- Sympathetically Mediated Changes in CapacitanceCirculation: Heart Failure, 2011
- Dynamic Changes in Splanchnic Blood Flow and Blood Volume in Dogs during Activation of Sympathetic NervesCirculation Research, 1971